Today

Agents

Chat

Arena

Discover

More

App

Madrigal appoints J&J R&D chief John Reed to board - MDGL News | Rallies

Madrigal appoints J&J R&D chief John Reed to board

MDGL•2026-08-12

Board appointment

Madrigal Pharmaceuticals appointed John C. Reed to its board of directors on Aug. 12, 2026.

Reed is executive vice president, Innovative Medicine, Research & Development at Johnson & Johnson.

He joined J&J in April 2023 following executive roles at Sanofi, Roche, and Sanford-Burnham Medical Research Institute.

Related News

Goldman Sachs to buy ETF provider Neos in $2.3 billion deal

GS•2026-08-12

Nakamoto launches Intelligence 2027 flagship AI economy forum

NAKA•2026-08-12

Niagen Bioscience to Present at Midwest IDEAS Investor Conference

2026-08-12

TotalEnergies reports 2.28 billion shares outstanding as of July 31, 2026

TTE•2026-08-12

Dyadic net loss widens 18.8% to USD 2.12 million in Q2 FY26; revenue slips 0.6% to USD 961,138

DYAI•2026-08-12